Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
7
×
eli lilly
7
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
europe blog main
fda
europe top stories
indiana blog main
indiana top stories
national top stories
san francisco blog main
blueprint medicines
cancer
cancer drugs
san francisco top stories
abbvie
amgen
avapritinib
boehringer ingelheim
boston
deals
europe
genentech
medullary thyroid cancer
new york blog main
new york top stories
non-small cell lung cancer
novartis
pralsetinib
raleigh-durham blog main
raleigh-durham top stories
roche
selpercatinib
thyroid cancer
alkermes
allergan
allergan aesthetics
What
drug
7
×
fda
approval
cancer
medicines
blueprint
designed
eli
lilly
new
ret
won
acquisitions
acute
address
addresses
alkermes
antipsychotic
approves
benefits
bid
biggest
bio
biotech
black
boehringer
build
buy
candidate
carries
causes
caveats
ceo
certain
clinic
commonly
companies
company’s
condition
currently
Language
unset
7
×
Current search:
drug
×
biotech
×
unset
×
" eli lilly "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades